Diltiazem increases the AUC of
intravenous and oral
methylprednisolone.
The
clinical significance of this interaction is unclear. It has been suggested that patients should be monitored for
methylprednisolone adverse effects (e.g. fluid retention, hypertension and hyperglycaemia), and this seems a prudent precau- tion.